Mindray is in the crosshairs of the FDA again. China's largest medical device company received a Nov. 29 warning letter for several quality system violations.

An increasing number of factors thwart efforts to bring new technologies to patients suffering from cardiovascular disease. In the minds of physician researchers and industry leaders, regulatory barriers, less financial return on investment and government impediments interfere with innovation. However, if innovators can adapt and evolve to a more global healthcare ecosystem, a silver lining may materialize.

“IT plays an integral role in all of our strategies,” says Patrick Gandy, Jr., MBA, senior vice president and COO of Lafayette General Medical Center in Lafayette, La., which has earned numerous accolades for delivering high-quality healthcare. “IT touches every part of the organization,” and the organization could not have achieved its success without it.

This begins a three-part series describing what mobile network operations or mobile telecommunication vendors can offer healthcare, as well as the possible downsides of using the mobile telecommunications products.

Every few months another study warns of a severe shortage of primary care physicians (PCPs) in the future. A recent report published in the Annals of Family Medicine explained how we will require 52,000 more PCPs by 2025 due to population growth, aging demographics and insurance expansion.

The FDA has issued a draft guidance in the Federal Register containing design considerations for medical device manufacturers developing products intended for home use.

Another new year already? Time sure flies when you’re engrossed in Meaningful Use, decision support, EHR implementation and other efforts geared to improving outcomes and reducing costs.

Looking back on 2012 brings so many topics, fascinating speakers and amazing innovations to mind. Meaningful Use powered along with the publication of both the final rule for Stage 2 and the proposed rule for Stage 3.